IMMUNOLOGY AND INFECTIOUS DISEASE38IMMUNOLOGY ANDINFECTIOUS DISEASEThe Immunology and Infectious Disease stream aims to increase our knowledgeand understanding of the infectious organisms that cause disease in humansand animals, and of the immune system that fights these organisms.During the year, 70 immunology andinfectious disease awards were made,including 15 new programme grantsor renewals, to a total value of£26.6 million.Research funded in the immunologyand infectious disease area rangedfrom fundamental and applied researchin basic immunology and infectiousdiseases conducted in the UK throughto field, epidemiological and clinicalresearch based in developing countries.Professor Brian Spratt, Imperial College,had the programme grant associated withhis Principal Research Fellowship renewedat a cost of £1.7 million. Professor Spratt,who has been a Principal Research Fellowsince 1989, studies the epidemiology andevolution of bacterial populations, and haspioneered the use of multi-locussequence typing as a scientific andepidemiological tool.Senior Research Fellowships in BasicBiomedical Science were awarded toDr Allison Green, University of Cambridge,for studies into inflammation andautoimmune disease, and to Dr Danielvan Aalten, University of Dundee, forhis studies on structural biology andinhibitor design in chitin metabolism.Fifteen programme grants were awarded,including grants to:• Professor Jose Vazquez-Boland, whomoved from the University of Leon inSpain to take up the Chair of VeterinaryMolecular Microbiology at the Universityof Bristol, for his studies of themolecular and cellular pathogenesis ofListeria infection. Listeriosis has one ofthe highest hospitalisation and mortalityrates of all food-borne infections.Professor Vazquez-Boland isinvestigating the actin-basedmechanism of cell–cell spread usedby the bacterium.• Dr Gavin Wilkinson, University of WalesCollege of Medicine, Cardiff, for studiesinto human cytomegalovirus. Thisherpesvirus is able to evade theimmune system of healthy but infectedpersons, but in immunocompromisedindividuals it presents a major clinicalproblem. Using clinical isolates,Dr Wilkinson will look at how the virusinteracts with natural killer cells, themain weapon in fighting viral disease.The team will use whole genomecloning techniques to investigate therole of different viral genes in evadingthese immune cells.• Professor David Wraith, Universityof Bristol, for research on thedifferentiation and stability of inducedregulatory T cells. Professor Wraith’sresearch is aimed at the developmentof therapies to control autoimmuneconditions, such as multiple sclerosis.Under the Tropical MedicineProgramme, awards included a SeniorClinical Fellowship in Tropical Medicineto Dr Elizabeth Corbett, London Schoolof Hygiene and Tropical Medicine, fortrials of TB case-finding strategies in anurban community in Zimbabwe severelyaffected by HIV, and a CareerDevelopment Fellowship to Dr CameronSimmons, University of Oxford, for hisstudies in Vietnam on cellular immuneresponse and disease pathogenesisduring dengue infection. Dr Corbettwas awarded the <strong>2004</strong> Chalmers medalby the Royal Society of Tropical Medicineand Hygiene for her contributions totropical medicine.An interim review was carried out of the<strong>Wellcome</strong> <strong>Trust</strong>/Burroughs <strong>Wellcome</strong>Fund Infectious Diseases Initiative.Launched in 1999, the initiative awarded£18 million to support 13 projects, eachinvolving partners in the UK, USA and adeveloping country, and has played animportant role in fostering internationalpartnerships and developing capacity.While many projects have yet to cometo full fruition, it is clear that they havedelivered major benefits to the participantsand host institutions, and in some caseshave had a direct impact on publichealth. For example, the project basedin Bangladesh has raised the profileof neonatal healthcare locally, attractingthe interest of the Ministry of Health andother NGOs/charities (see page 27).Major Overseas ProgrammesFollowing a favourable review in <strong>2004</strong>,an award of £2.3 million was madeto the University of Liverpool for theMalawi–Liverpool–<strong>Wellcome</strong> <strong>Trust</strong>Clinical Research Programme. Theprogramme, which is led by ProfessorMalcolm Molyneux and is based in the<strong>Wellcome</strong> <strong>Trust</strong> Research Laboratoriesat the University of Malawi College ofMedicine, Blantyre, conducts researchinto malaria, HIV, TB and other bacterialand viral infections, and anaemia.In addition to research costs, the awardprovides funds to support the trainingof local researchers associated with theprogramme (see page 25).In Kenya building work began on newlaboratories in Kilifi for the <strong>Wellcome</strong><strong>Trust</strong>/Kenya Medical Research InstituteResearch Programme, led by ProfessorKevin Marsh. The building has beenfunded by a <strong>Wellcome</strong> <strong>Trust</strong> grant of£2.75 million to the Kenya MedicalResearch Institute. The building shouldbe completed by August 2005.Research highlights from the Kenyaprogramme include:• The completion of a survey of epilepsyin over 160 000 people and theidentification of all cases of activeepilepsy, the largest study of its kindever conducted in Africa.
IMMUNOLOGY AND INFECTIOUS DISEASE39• Analysis of data on the spectrumof bacteraemia in children, with datafrom over 20 000 children admittedto hospital. Of all hospital deaths,14 per cent were attributable toStreptococcus pneumoniae andHaemophilus influenzae, for whicheffective vaccines are available butonly partially implemented.• Dr Sam Kinyanjui and Dr Faith Osierwere awarded Research TrainingFellowships for Scientists fromDeveloping Countries to conductresearch at the KEMRI–<strong>Wellcome</strong><strong>Trust</strong> programme in Kilifi.In South-east Asia, whichencompasses research centres inThailand (led by Professor Nick Day)and Vietnam (Professor Jeremy Farrar),research highlights include:• Demonstration that variable horizontalgene acquisition by Burkholderiapseudomallei is an important featureof its recent genetic evolution.• Continued translation of theProgramme’s research results intohealth policy. Biological, economicand clinical evidence from the researchpublications of the programme haveprovided a basis for a change in globalantimalarial treatmentrecommendations to artemisinincombination therapies (ACTs)(see page 24).• A mathematical–economic modelof drug resistance has been usedas a basis for the globalrecommendations on antimalarialdrug policy issued in a recentInstitute of Medicine report (SavingLives, Buying Time).• In Vietnam, the Programme hascompleted the largest-ever studyof TB meningitis (see page 26).• The Vietnam Programme has beenat the forefront of the battle againstthe outbreak of avian flu (seepage 23).• The New Adult Intensive CareUnit at the Hospital for TropicalDiseases opened in <strong>2004</strong>, fundedjointly by the Vietnamese Governmentand the <strong>Wellcome</strong> <strong>Trust</strong>.The <strong>Wellcome</strong> <strong>Trust</strong> Centrefor Molecular ParasitologyThe <strong>Wellcome</strong> <strong>Trust</strong> Centre for MolecularParasitology at the University of Glasgow,led by Professor Dave Barry, carries outresearch on basic features of parasites,using genetic and molecular technologyallied with organismal biology. One aimis that such studies will lead to novelcontrol approaches.Much of the research at the Centreconcerns African trypanosomes,microscopic parasites that cause humansleeping sickness and the wastingdisease nagana in domestic animals.The malaria parasite, Plasmodium,and a related parasite, Theileria, whichinfects cells of the cattle immune system,are also studied at the Centre.In <strong>2004</strong>, the Centre established a newpartnership with INSERM, the nationalmedical research agency of the FrenchGovernment. INSERM has begun tolocate its researchers in universitiesabroad, and the first of these INSERMResearch Units, led by ProfessorChristian Doerig, has been establishedat the Centre.During the year, a programme grantwas awarded to Professor Andy Taitat the Centre, based on his applicationof genetics to the identification ofimportant trypanosome genes. ProfessorTait’s mapping and annotation of thetrypanosome genome has beeninvaluable to the genome sequencingwork on the parasite being carried outat the <strong>Wellcome</strong> <strong>Trust</strong> Sanger Instituteand elsewhere.www.gla.ac.uk/centres/wcmp/index.htmlAdenovirus particles.